90 related articles for article (PubMed ID: 7904543)
1. Sulfasalazine may interfere with HPLC assay of urinary pyridinium crosslinks.
Peel N; al-Dehaimi A; Colwell A; Russell G; Eastell R
Clin Chem; 1994 Jan; 40(1):167-8. PubMed ID: 7904543
[No Abstract] [Full Text] [Related]
2. The effects of sulphasalazine on urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis.
Dílek K; Alí I; Göksal K; Hüseyin T; Güner T
Yonsei Med J; 2002 Aug; 43(4):435-40. PubMed ID: 12205730
[TBL] [Abstract][Full Text] [Related]
3. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases.
Seibel MJ; Duncan A; Robins SP
J Rheumatol; 1989 Jul; 16(7):964-70. PubMed ID: 2769668
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of urinary pyridinoline in healthy adults and patients with rheumatoid arthritis by an improved high-performance liquid chromatographic assay.
Otsuka M; Kurosaka R; Kim JS; Kawai S; Arakawa N
J Nutr Sci Vitaminol (Tokyo); 1996 Oct; 42(5):485-90. PubMed ID: 8981254
[TBL] [Abstract][Full Text] [Related]
5. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis.
Hein G; Franke S; Müller A; Bräunig E; Eidner T; Stein G
Clin Rheumatol; 1997 Mar; 16(2):167-72. PubMed ID: 9093799
[TBL] [Abstract][Full Text] [Related]
6. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
[TBL] [Abstract][Full Text] [Related]
7. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography.
Pratt DA; Daniloff Y; Duncan A; Robins SP
Anal Biochem; 1992 Nov; 207(1):168-75. PubMed ID: 1489091
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography.
Black D; Duncan A; Robins SP
Anal Biochem; 1988 Feb; 169(1):197-203. PubMed ID: 3369682
[TBL] [Abstract][Full Text] [Related]
9. Physiological variations in the urinary excretion of pyridinium crosslinks of collagen.
McLaren AM; Isdale AH; Whiting PH; Bird HA; Robins SP
Br J Rheumatol; 1993 Apr; 32(4):307-12. PubMed ID: 8461924
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis.
Black D; Marabani M; Sturrock RD; Robins SP
Ann Rheum Dis; 1989 Aug; 48(8):641-4. PubMed ID: 2490853
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases.
Müller A; Jakob K; Hein GE
Ann Rheum Dis; 2003 Jan; 62(1):65-7. PubMed ID: 12480673
[TBL] [Abstract][Full Text] [Related]
12. Receiver operating characteristic analysis of urinary pyridinium cross-links in arthritis.
Takahashi M; Kushida K; Inoue T
Br J Rheumatol; 1995 Aug; 34(8):792-3. PubMed ID: 7551670
[No Abstract] [Full Text] [Related]
13. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis.
Gough AK; Peel NF; Eastell R; Holder RL; Lilley J; Emery P
Ann Rheum Dis; 1994 Jan; 53(1):14-7. PubMed ID: 8311548
[TBL] [Abstract][Full Text] [Related]
14. Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis.
al-Awadhi AM; Olusi SO; al-Zaid NS; Prabha K; al-Jarallah KH; Ahmed AH; al-Salem I; Sedeqi H; Atteyah Y
Clin Exp Rheumatol; 1998; 16(5):569-72. PubMed ID: 9779304
[TBL] [Abstract][Full Text] [Related]
15. Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis.
Sinigaglia L; Varenna M; Binelli L; Bartucci F; Arrigoni M; Ferrara R; Abbiati G
Ann Rheum Dis; 1995 Feb; 54(2):144-7. PubMed ID: 7702405
[TBL] [Abstract][Full Text] [Related]
16. Monitoring collagen degradation in patients with arthritis. The search for suitable surrogates.
Greenwald RA
Arthritis Rheum; 1996 Sep; 39(9):1455-65. PubMed ID: 8814056
[No Abstract] [Full Text] [Related]
17. Urinary excretion of amino acids in rheumatic diseases.
LANDTMAN B; VISAKORPI JK
Ann Paediatr Fenn; 1960; 6():299-308. PubMed ID: 13758697
[No Abstract] [Full Text] [Related]
18. Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis.
Takahashi M; Suzuki M; Naitou K; Miyamoto S; Kushida K
Rheumatology (Oxford); 1999 Feb; 38(2):133-8. PubMed ID: 10342625
[TBL] [Abstract][Full Text] [Related]
19. Pyridinium crosslinks excretion in patients with rheumatoid arthritis. Correlation with disease activity and glucocorticoid treatment.
Xuereb Anastasi A; Buhagiar A; Camilleri F; Cauchi M; Mallia C
Adv Exp Med Biol; 1999; 455():227-33. PubMed ID: 10599348
[TBL] [Abstract][Full Text] [Related]
20. Hydroxypyridinium collagen crosslinks in serum, urine, synovial fluid and synovial tissue in patients with rheumatoid arthritis compared with osteoarthritis.
Kaufmann J; Mueller A; Voigt A; Carl HD; Gursche A; Zacher J; Stein G; Hein G
Rheumatology (Oxford); 2003 Feb; 42(2):314-20. PubMed ID: 12595629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
